Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Guggenheim

Is Rivian Stock a Buy After Its Billion-Dollar Cash Injection?

Rivian stock broke out following a massive cash injection from a legacy automaker, but is the EV startup a good investment right now?

Barchart · Jul 5, 2024

A guide to Frank Gehry's architecture: mesmerising, expressive and sometimes controversial

Canadian-American Frank Gehry has earned his position in the hall of fame of contemporary architects through a wealth of groundbreaking designs; here, we explore why, how, and his key projects

Wallpaper · May 3, 2024

Eyewash, irreverence and a Bruce Springsteen concert: on the road with a pioneering performance poet

The Tour is Pi O’s verse diary about a small group of Australian poets who take their wares on the road in North America in the mid-1980s, sponsored by the Literature Board and the Guggenheim Foundation. This came to be known as “The Dirty T-Shirt Tour”, because Pi O’s dress…

The Conversation · Nov 13, 2023

From analysis to the latest developments in health,
read the most diverse news in one place.

'Real joy' to be had viewing Kandinsky's art in Sydney

New York's famed Guggenheim Museum has lent key paintings by Vasily Kandinsky to the Art Gallery of NSW for a major exhibition.

AAP · Nov 2, 2023

‘She should be up there with the greatest’: celebrating the art of Gego

Fleeing Nazi Germany and ending up in Venezuela, the unusual artist found a career crafting offbeat sculptures, on display in a new exhibition

The Guardian - US · Jun 13, 2023

'Bilbao is full of culture, ludicrously cheap wine and delicious pintxos'

The Guggenheim museum in Bilbao has just celebrated its 25th birthday and, encased as it is in more than 30,000 titanium sheets and is fronted by artist Jeff Koons’ 39ft-high Puppy, it is still quite the landmark

Daily Mirror · Feb 14, 2023

'All the Beauty and the Bloodshed' chronicles Nan Goldin's career of art and activism

Filmmaker Laura Poitras and Goldin discuss their Oscar-nominated documentary about efforts to remove the Sackler family name from prominent museums amid the opioid epidemic.

WEKU · Feb 9, 2023

Read news from The Economist, FT, and more,
with one subscription

Artist Nan Goldin on addiction and taking on the Sackler dynasty: ‘I wanted to tell my truth’

Her battle against the billionaires who fuelled the opioid epidemic upended the art establishment. As a film about her life is released, she talks about family tragedy and her journey to activism

The Guardian - UK · Dec 4, 2022

Benzinga's Top Ratings Upgrades, Downgrades For November 7, 2022

Upgrades

Benzinga · Nov 7, 2022

Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022

Upgrades

Benzinga · Oct 31, 2022

Meta Platforms To $200? These Analysts Slash Price Targets On Meta Following Q3 Results

Meta Platforms, Inc. (NASDAQ: META) reported worse-than-expected Q3 EPS and issued Q4 revenue guidance with a midpoint below estimates. The company also guided FY23 expenses of $96 billion to $101 billion. Meta Platforms shares dropped 22.1% to $101.20 on Thursday.

Benzinga · Oct 27, 2022

Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2022

Upgrades

Benzinga · Oct 24, 2022

Etsy Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bearish stance on Etsy. Looking at options history for Etsy (NASDAQ:ETSY) we detected 27 strange trades.

Benzinga · Oct 13, 2022

Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022

Upgrades

Benzinga · Oct 13, 2022

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga · Oct 10, 2022

Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2022

Upgrades

The Conversation · Sep 20, 2022

Women artists: the belated craze for blockbuster shows is welcome – but it's not enough

The Barbican’s boldly curated exhibiton of abstract expressionist Lee Krasner (1908-1984) – who was routinely referred to as Jackson Pollock’s wife, despite being a well-established artist long before meeting him – transferred to the Guggenheim Bilbao in 2018. Before it opened, a Spanish newspaper invited me to introduce this “little…

Benzinga · Sep 9, 2022

Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022

Upgrades

The Independent UK · Sep 3, 2022

Laura Poitras film spotlights activist photographer Goldin

Laura Poitras' Nan Goldin documentary "All the Beauty and the Bloodshed,” is having its world premiere at the Venice Film Festival on Saturday, where it is part of the main competition slate

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga · Sep 2, 2022

Benzinga's Top Ratings Upgrades, Downgrades For September 2, 2022

Benzinga · Aug 19, 2022

5 Kohl's Analysts On Bloated Inventory, Guidance Cut: 'Fundamentals Are Likely To Get Worse'

Kohl's Corporation (NYSE: KSS) shares are down 4% on Friday after the company cut its guidance and said inflation is eating into its sales growth.

Tribune News Service · Jul 20, 2022

Minneapolis-published Ada Limón is named US Poet Laureate

The Guggenheim fellow has published four books of poetry with Minneapolis' Milkweed Editions.

Benzinga · Jul 5, 2022

Read How Analysts Reacted To Kohl's Conclusion Of Strategic Review Process

Telsey Advisory Group analyst Dana Telsey has lowered the price target on Kohl's Corp (NYSE:KSS) to $35 (19% upside) from $55 and kept the Market Perform rating on the shares. Kohl's abandoned its negotiations with Franchise Group, considering the challenges in the current retail and financing environment. Also, the retail chain has cut its Q2 sales guidance on ongoing inflationary…

Daily Mirror · May 25, 2022

New Chelsea owner Todd Boehly - how rich is he and how did he make his money?

Todd Boehly is to be the new face of Chelsea Football Club, as his consortium secures permission to complete the sale of the west London outfit from Roman Abramovic after he bought it in 2003

The Guardian - UK · May 25, 2022

Todd Boehly’s vision for Chelsea? Glossy spectacle and ruthless profit

Judging by his time with the Los Angeles Dodgers, Boehly will sanction big spending as long as he sees even bigger returns

Benzinga · May 24, 2022

SVB Sees De-Risked Opportunity For This Newly Listed Norovirus Vaccine

SVB Leerink is initiating coverage of HilleVax Inc (NASDAQ:HLVX) shares with an Outperform rating and a $30 price target. The analyst believes the company’s potentially first-in-class infant norovirus vaccine HIL214 represents a uniquely de-risked opportunity. It estimates $625 million in risk-adjusted infant HIL214 sales in 2030E ($1 billion unadjusted). The outlook is supported by…

1 2 3 4 5

Coverage From

People

Artemisia Gentileschi

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.